Arrowhead Pharmaceuticals Inc (ARWR)
Equity Ratio
22.04%
Quarterly · Period ending:
ARWR Equity Ratio
Latest reported22.04%period ending
Latest reported22.04%period ending
ARWR Quarterly Equity Ratio (-2600.00% → 22.04%)
Latest values, visible window
High-resolution chart · PNG
ARWR equity ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Equity Ratio |
|---|---|
| 22.042% | |
| 27.0681% | |
| 35.4338% | |
| 33.6428% | |
| 37.832% | |
| 43.4269% | |
| 5.1879% | |
| 16.2698% | |
| 37.4024% | |
| 50.6511% | |
| 25.6124% | |
| 35.4441% | |
| 45.8412% | |
| 50.1254% | |
| 42.2932% | |
| 57.5947% | |
| 60.3801% | |
| 64.2811% | |
| 58.3457% | |
| 57.5686% | |
| 59.4467% | |
| 58.8731% | |
| 91.0308% | |
| 88.3781% | |
| 88.7377% | |
| 88.0663% | |
| 85.1059% | |
| 69.9141% | |
| 67.1633% | |
| 60.2489% | |
| 50.4639% | |
| 85.8312% | |
| 90.6216% | |
| 89.9774% | |
| 80.2019% | |
| 78.274% | |
| 78.2901% | |
| 74.0053% | |
| 67.7699% | |
| 74.5686% | |
| 70.125% | |
| 78.7268% | |
| 83.4285% | |
| 83.2982% | |
| 90.4327% | |
| 89.1445% | |
| 90.2108% | |
| 91.0969% | |
| 94.7819% | |
| 94.4521% | |
| 89.2538% | |
| 73.6644% | |
| 84.257% | |
| 42.7792% | |
| 58.9239% | |
| 60.5805% | |
| 56.8004% | |
| 60.9323% | |
| 70.1106% | |
| 80.5051% | |
| 79.9542% | |
| 79.3156% | |
| 52.9894% | |
| 73.2176% | |
| 69.2866% | |
| 75.7621% | |
| 73.0758% | |
| 63.0723% | |
| 45.3004% | |
| 3.9937% | |
| 32.4889% | |
| 71.297% | |
| 68.4937% | |
| 76.8024% | |
| 77.5208% | |
| 88.1118% | |
| 90.3581% | |
| 90.9765% | |
| 87.6973% | |
| 88.8354% | |
| 92.7109% | |
| 91.3816% | |
| 90.1498% | |
| 89.9684% | |
| 92.6717% | |
| 85.4711% | |
| 82.0552% | |
| 79.293% | |
| 89.2916% | |
| 99.6662% | |
| 99.0444% | |
| 93.6556% | |
| -3,803.8124% | |
| -3,928.982% | |
| -3,341.9455% | |
| -2,439.6737% | |
| -1,395.0098% | |
| -2,751.6266% | |
| -2,813.8995% | |
| -2,817.1342% |